Publication about positive outcome following the use of the SupStance Distractor - The European Spine Journal
For more informations, please contact JC Lehuec (FR) : j-c.lehuec@u-bordeaux2.fr

Video-assisted treatment of thoracolumbar junction fractures using a specific distractor for reduction: prospective study of 50 cases  
Jean-Charles Le Huec - C.Tournier -S. Aunoble - K. Madi - Ph. Leijssen

Abstract: Posterior instrumentation allows good osteosynthesis for thoracolumbar junction fractures. However, in approximately 20% of cases, anterior bone defects may persist, leading to pseudoarthrosis and loss of reduction. Anterior approaches can circumvent this drawback, but they are considered aggressive with a high rate of complications.The advent of the endoscopic mini-invasive techniques has led to a reduction in the number of complications while maintaining the same consolidation rate.Nevertheless, poor restitution of anatomic curves is a reproach for this technique. This prospective study reports clinical and radiological result of 50 patients (19 women and 31 men) operated between April 2000 and March 2006 with a video-assisted anterior approach using an endodistractor for reduction and consequent insertion of the implant. There were A3 (n = 44), A2 (n = 2), A1 (n = 3) and C1 (n = 1) fractures (Magerl classification). The specific system for fracture reduction was used in the last 39 cases of this series. A Pyramesh cage (Medtronic, Memphis,USA) was used in 15 patients, a peek cage (Creaspine, Bordeaux, France) in 30 patients and a tricorticalgraft in 5 patients. Standard X-rays and CT scan were performed pre-operatively. Kyphosis, and angulations were measured pre-, per- and post-operatively. Mean immediate postoperative gain in localized kyphosis was 12.18  and mean gain at last follow-up was 11.71 . Mean immediate postoperative gain in RA was 13.24  and remained identical at last follow-up. Five patients had a transient pulmonary atelectasia and there was one pulmonary infection. No neurological complication occurred. Fracture reduction is comparable to the best thoracotomy series while limiting approach-related complications.

Creaspine joins forces with leading... 2010/06
Positive ISO 13485:2003 certificati... 2010/04
Successful US FDA Audit 2010/02
Creaspine will attend the NASS 2009... 2009/11
Creaspine will attend the EuroSpine... 2009/10
Publication about positive outcome ... 2009/09
3 years for Creaspine! 2009/01
Creaspine's SupStance™ PEEK V... 2008/01
Back home
Creaspine's news
Company profile
Beliefs and focus
Products US
Products international
Creaspine | Plateforme Technologique d’Innovation Biomédicale | Hôpital Xavier Arnozan | Av. du Haut-Lévêque 33600 Pessac - France - Phone : +33 (0)5 57 10 28 54